SN
Satya Nand Reddy
About Satya Nand Reddy
Data last updated:
Satya Nand Reddy is a Director at Breathx Technologies Private Limited (since 2021) and Director at Digigene Diagnostics Private Limited (since 2022). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Breathx Technologies Private Limited at ₹6.73 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Breathx Technologies Private Limited U52311MH2020PTC336475 | Director | 21 Jan 2021 | 2020 | ₹6.73 Cr (FY 2022) | Active |
| Digigene Diagnostics Private Limited U33100KA2021PTC147370 | Director | 24 Feb 2022 | 2021 | Active |
Board colleagues of Satya Nand Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arif Mohammed Shaik | 09245941 | Breathx Technologies Private Limited , Digigene Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Nand Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Nand Reddy
Satya Nand Reddy currently holds 2 directorships: Breathx Technologies Private Limited (Director, since 21 Jan 2021, revenue ₹6.73 Cr (FY 2022)); Digigene Diagnostics Private Limited (Director, since 24 Feb 2022).
Satya Nand Reddy was first appointed on 21 Jan 2021 as Director at Breathx Technologies Private Limited. The most recent appointment on record is 24 Feb 2022 at Digigene Diagnostics Private Limited.
The current boards of Satya Nand Reddy's companies include Arif Mohammed Shaik (Breathx Technologies Private Limited).